Molecular genetic advances in pituitary tumor development
Christopher J Yates, Kate E Lines, Rajesh V Thakker
Expert Review of Endocrinology & Metabolism | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | Published : 2015
Awarded by United Kingdom Medical Research Council (MRC) programme
This work was supported by the: United Kingdom Medical Research Council (MRC) programme grants (G9825289 and G1000467 to KE Lines and RV Thakker); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (to KE Lines and RV Thakker); Royal Australasian College of Physicians Vincent Fairfax Family Foundation Research Fellowship (to CJ Yates); Australia Awards Endeavour Postgraduate Research Fellowship Award (to CJ Yates); Novartis Pharmaceuticals Australia Educational Grant (to CJ Yates); Ipsen Pharmaceuticals Australia Educational Grant (to CJ Yates) and The Unicorn Foundation Educational Grant (to CJ Yates). RV Thakker is a member of an ad hoc panel for Novartis (fees paid to institution); has received lecture fees at a sponsored conference from Novartis, Ipsen, Novo Nordisk and Eli Lilly (fees paid to institution) and is Chairman of AstraZeneca advisory group (fees paid to institution). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.